News
News releases on November 4, 2026, page 12
Every news release public companies put out on November 4, 2026 (UTC): 4,078 news releases, newest first. Open any release to read it.
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and E...
Hemab Therapeutics Holdings, Inc. · Nov 4, 2026
Feedonomics Now Available in Amazon’s Shop Direct Merchant Workspace, Making it Easier for Brands to Get Their Products in Front of Amazo...
Commerce.com, Inc. - Series 1 · Nov 4, 2026
Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference
Dare Bioscience, Inc. · Nov 4, 2026
Actinium Pharmaceuticals Announces ASH 2026 Abstract Highlighting Long-Term Results of Actimab-A in Combination with CLAG-M in Relapsed o...
Actinium Pharmaceuticals, Inc. (Delaware) · Nov 4, 2026
Voluntary announcement - attendance of the chairman of the board at the 2026 united nations climate change conference (COP31) and related...
China Carbon Neutral Development Group Limited · Nov 4, 2026
Holding(s) in Company
Advanced Medical Solutions Group plc · Nov 4, 2026
Overseas regulatory announcement
Metasurface Technologies Holdings Limited · Nov 4, 2026
Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission
Lyell Immunopharma, Inc. · Nov 4, 2026
Kura Oncology and Kyowa Kirin to Present First Ziftomenib-FLT3 Inhibitor Clinical Data at ASH 2026
Kura Oncology, Inc. · Nov 4, 2026
Northrop Grumman to Participate in the Baird 2026 Global Industrial Conference
Northrop Grumman Corporation · Nov 4, 2026
Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026
Syndax Pharmaceuticals, Inc. · Nov 4, 2026
Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annu...
City Therapeutics, Inc. · Nov 4, 2026
Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and ...
Lyell Immunopharma, Inc. · Nov 4, 2026
Karyopharm to Present Selinexor Data in Patients with Myelofibrosis and Multiple Myeloma at the 68th American Society of Hematology Annua...
Karyopharm Therapeutics Inc. · Nov 4, 2026
Immunome to Present Initial First-in-Human Clinical Data for IM-1021 in Advanced B-Cell Lymphomas at ASH 2026
Immunome, Inc. · Nov 4, 2026
Grant of share options
Ascletis Pharma, Inc. · Nov 4, 2026
CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annu...
CRISPR Therapeutics AG · Nov 4, 2026
Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (...
Corvus Pharmaceuticals, Inc. · Nov 4, 2026
Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease ...
Agios Pharmaceuticals, Inc. · Nov 4, 2026
Voyager Awarded $35M Contract to Manage NASA HUNCH
Voyager Technologies, Inc. · Nov 4, 2026
Vox Royalty Provides Update & Timeline for Assets Entering Production
Vox Royalty Corp · Nov 4, 2026
Vivakor Highlights Direct Midstream’s New Mexico Operating Agreement as Proposed Acquisition Advances
Vivakor, Inc. · Nov 4, 2026
The FUTR Corporation Launches FUTR Agent Leads, Pairing Every Lead with a Business Agent and the FUTR Agent App
FUTR Corporation · Nov 4, 2026
TD SYNNEX Report: AI Spending Is Surging, but Revenue Isn’t Keeping Pace
TD SYNNEX Corporation · Nov 4, 2026
Syndax Highlights Acceptance of 19 Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Abstracts, Including 7 for Oral Presentation, at...
Syndax Pharmaceuticals, Inc. · Nov 4, 2026
ShelfieTech Announces Closing of Acquisition of Majority Interest in Aspect
Shelfie-Tech Ltd. · Nov 4, 2026
SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in...
SELLAS Life Sciences Group, Inc. · Nov 4, 2026
Scotiabank to Announce Fourth Quarter 2026 Results
Bank of Nova Scotia · Nov 4, 2026
Sallie Awards $500,000 in Scholarships to Help Students Advance Their Education and Career Goals
SLM Corporation · Nov 4, 2026
Royale Energy to Commence Trading on OTCQB® Venture Market
Royale Energy, Inc. · Nov 4, 2026
Overseas regulatory announcement
Metasurface Technologies Holdings Limited · Nov 4, 2026
OneStream Named Leader and Ranked Number One Overall in the 2026 ISG Buyers Guides™ for Record to Report, Financial Close, and Financial ...
OneStream, Inc. · Nov 4, 2026
Next Day Disclosure Return
Alebund Pharmaceuticals (Jiangsu) Limited · Nov 4, 2026
Netskope to Report Fiscal Third Quarter 2027 Financial Results on December 2, 2026
Netskope, Inc. · Nov 4, 2026
MGE Energy Reports Third-Quarter 2026 Earnings
MGE Energy Inc. · Nov 4, 2026
Marsh Completes Acquisition of AltamarCAM
Marsh · Nov 4, 2026
Marriott International Celebrates 800th Property in Asia Pacific excluding China with the Opening of La Résidence Phou Vao, a Luxury Coll...
Marriott International · Nov 4, 2026
LiveOne (NASDAQ: LVO) Extinguishes $8.5 Million in JGB Debt, Reducing Balance from $17.5 Million to $9 Million
LiveOne, Inc. · Nov 4, 2026
Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
Lexaria Bioscience Corp. · Nov 4, 2026
Leidos introduces HeadWay Dispatch for AI agent oversight
Leidos Holdings, Inc. · Nov 4, 2026
Legend Biotech to Showcase CARVYKTI® Leadership and Next-Generation Cell Therapy Innovation at ASH 2026
Legend Biotech Corp. · Nov 4, 2026
Kelly® Earns Leader Recognition on Everest Group’s U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix®
Kelly Services, Inc. · Nov 4, 2026
Invesco Ltd. to Participate in the BMO Financials Conference
Invesco Ltd · Nov 4, 2026
Guided Therapeutics Provides Update on its Cervical Cancer Screening Study with Türkiye’s Ministry of Health
Guided Therapeutics, Inc. · Nov 4, 2026
Global Financial Inclusion Index From Principal® Reaches Five-Year High; Fewer People Feel the Benefit
Principal Financial Group Inc · Nov 4, 2026
Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026
Geron Corporation · Nov 4, 2026
Gateway Mortgage Selects ICE’s MSP and Integrated Servicing Solutions to Enhance Servicing Operations and Customer Experience
Intercontinental Exchange Inc. · Nov 4, 2026
Flowers Foods elects two new members to board of directors
Flowers Foods, Inc. · Nov 4, 2026
Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 M...
Evaxion A/S · Nov 4, 2026
Elastic’s Threat Report Reveals Attackers Are Turning Trusted AI and IT Tools Against the Enterprises That Deploy Them
Elastic N.V. · Nov 4, 2026
Damora Therapeutics to Present New Preclinical Data Highlighting Potentially Best-in-Class Pan-Mutant Activity of DMR-001 in Mutant Calre...
Damora Therapeutics, Inc. · Nov 4, 2026
CSX Executive Vice President and Chief Financial Officer to Address Baird Global Industrial Conference
CSX Corporation · Nov 4, 2026
Credo and Oracle Advance Optical Transceiver Telemetry Standardization with OCP Community
Credo Technology Group Holding Ltd · Nov 4, 2026
Codere Online to Release Financial Results for the Third Quarter 2026 on November 12th
Codere Online Luxembourg, S.A. · Nov 4, 2026
Climb Bio to Present New Data for Budoprutug in Immune Thrombocytopenia at the 68th American Society of Hematology Annual Meeting and Exp...
Climb Bio, Inc. · Nov 4, 2026
Chilean Cobalt Corp. Signs Definitive Option Agreement to Consolidate Substantially All of the Past-Producing La Cobaltera Project Area
Chilean Cobalt Corp. · Nov 4, 2026
Cellectar Biosciences to Present Three Posters Highlighting Durable Clinical Activity of Iopofosine I 131 in Waldenström Macroglobulinemi...
Cellectar Biosciences, Inc. · Nov 4, 2026
Castor Maritime Announces that MPC Oceanic Group Has Entered into Agreement to Acquire a 41% Stake in Marlow Navigation
Castor Maritime Inc. · Nov 4, 2026
Casey’s Country Comes Together to Support America’s Military Community
Caseys General Stores, Inc. · Nov 4, 2026
Caribou Biosciences Announces Presentations at the 2026 American Society of Hematology (ASH) Annual Meeting
Caribou Biosciences, Inc. · Nov 4, 2026
BioMarin to Participate in Upcoming Investor Conferences
BioMarin Pharmaceutical Inc. · Nov 4, 2026
Beam Therapeutics to Present Updated Clinical Data from BEACON Phase 1/2 Trial of Risto-cel in Sickle Cell Disease in an Oral Presentatio...
Beam Therapeutics Inc. · Nov 4, 2026
AvePoint Appoints Ali Rohani as Chief Strategy and Customer Officer
AvePoint, Inc. · Nov 4, 2026
ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
ADC Therapeutics SA · Nov 4, 2026
MGE Energy: Reports Third-Quarter 2026 Earnings
MGE Energy Inc. · Nov 4, 2026
Overseas regulatory announcement
Metasurface Technologies Holdings Limited · Nov 4, 2026
Medical Care Technologies Inc. (OTCID: MDCE) Moves $250,000 Software Agreement Into Active Development
Medical Care Technologies Inc. · Nov 4, 2026
Hang Seng tech index ETF information
Hang Seng Invt. Series - Hang Seng TECH Index ETF · Nov 4, 2026
Inside information - mt bundy gold project latest metallurgical test results and development update
Hanking Gold International Limited · Nov 4, 2026
Completion of major transaction in relation to the disposal of suzhou property and facility
SinoMab Bioscience Ltd. · Nov 4, 2026
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics Inc. · Nov 4, 2026
Algoma Central Corporation Announces Closing of Convertible Debenture Financing
Algoma Central Corporation · Nov 4, 2026
Algoma Central Corporation Announces Closing of Convertible Debenture Financing
Algoma Central Corporation · Nov 4, 2026
Hang Seng China A Industry Top Index ETF information
Hang Seng China A Industry Top Index ETF · Nov 4, 2026
BWX Technologies, Inc. Launches Cash Tender Offers and Consent Solicitations for its 4.125% Senior Notes due 2028 and 4.125% Senior Notes...
BWX Technologies, Inc. · Nov 4, 2026
Overseas Regulatory Announcement
Guangzhou R&F Properties Co., Ltd. · Nov 4, 2026
Hs FCI50 ETF information
Hang Seng FTSE China 50 Index ETF · Nov 4, 2026
BWX Technologies, Inc. Announces Proposed Offering of Senior Notes
BWX Technologies, Inc. · Nov 4, 2026
Hang Seng China Enterprises Index ETF information
Hang Seng China Enterprises Index ETF · Nov 4, 2026
Company information sheet
C&N Holdings Limited · Nov 4, 2026
Net Asset Value(s)
FTAI Aviation Ltd. · Nov 4, 2026
List of directors and their role and function
C&N Holdings Limited · Nov 4, 2026
Voya Financial Expands its Multiple Employer Solutions as Business Nearly Doubles
Voya Financial, Inc. · Nov 4, 2026
Luxfer Shareholders Approve Acquisition by Wynnchurch Capital
Luxfer Holdings PLC · Nov 4, 2026
Supplemental information on the payment of 2026 interim dividend
Jiaxin International Resources Investment Limited · Nov 4, 2026
Material Information or Facts Report Press Release Financial Performance 3Q26 PT Jababeka Tbk
PT Kawasan Industri Jababeka Tbk · Nov 4, 2026
IonQ Completes Acquisition of Elisity, Extending Quantum Security for Enterprises and Government
IonQ, Inc. · Nov 4, 2026
TOMI Environmental Solutions, Inc. Announces Recurring Consumable Agreement with Global Eye Health Company
TOMI Environmental Solutions, Inc. · Nov 4, 2026
Siebert Financial Announces Next Generation Leadership Structure to Drive Continued Growth as Firm Enters 60th Year
Siebert Financial Corp. · Nov 4, 2026
PAVS Subsidiary 2Lab3 Launches AniMano+, an AI-Native Digital Entertainment Streaming Platform, on the Apple App Store
Paranovus Entertainment Technology Ltd. · Nov 4, 2026
OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models
OneMedNet Corp · Nov 4, 2026
Next Day Disclosure Returns
Zhengwei Group Holdings Company Limited · Nov 4, 2026
Net Asset Value(s)
FT Vest Nasdaq-100 Buffer ETF - December · Nov 4, 2026
Appointment of executive director
C&N Holdings Limited · Nov 4, 2026
Summary Information
Tracker Fund of Hong Kong · Nov 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026
Ocumension Therapeutics · Nov 4, 2026
Rule 2.9 Announcement
Advanced Medical Solutions Group plc · Nov 4, 2026
SeaStar Medical to Report Third Quarter Financial Results on November 11, 2026
SeaStar Medical Holding Corporation · Nov 4, 2026
Next Day Disclosure Return
Beijing Haizhi Technology Group Co., Ltd. · Nov 4, 2026
CRH announces Cash Tender Offers, Exchange Offers and Consent Solicitations for Arcosa, Inc. Notes
Arcosa, Inc. · Nov 4, 2026